Sd. Fihn et al., A COMPUTERIZED INTERVENTION TO IMPROVE TIMING OF OUTPATIENT FOLLOW-UP- A MULTICENTER RANDOMIZED TRIAL IN PATIENTS TREATED WITH WARFARIN, Journal of general internal medicine, 9(3), 1994, pp. 131-139
Objective: To evaluate a computerized scheduling model that employs no
nlinear optimization to recommend optimal follow-up intervals for pati
ents taking warfarin. Design: Randomized trial. Setting: 5 anticoagula
tion clinics. Patients/participants: 620 patients expected to receive
warfarin for greater-than-or-equal-to 6 weeks. Interventions: Computer
-generated recommendations for scheduling the next visit were presente
d to or withheld from practitioners. Measurements and main results: Th
e main outcome measures were the follow-up interval scheduled by the p
rovider, the interval at which the patient actually returned to clinic
, and the quality of anticoagulation control (computed as the absolute
difference between the measured and target prothrombin times [PTRs] o
r international normalized ratios [INRs]). Follow-up intervals schedul
ed for the patients whose practitioners received computer-generated re
commendations were significantly longer than those for control patient
s (mean, 4.4 vs 3.5 weeks, p < 0.001), despite the fact that the pract
itioners modified the suggested return interval by > 1 week on 40% of
the visits. The interval at which the intervention group actually retu
rned to clinic was also longer (mean, 4.4 vs 4.1 weeks, p < 0.05), eve
n though the control patients tended to return at longer intervals tha
n were scheduled by their practitioners. Control of anticoagulation wa
s nearly the same among experimental and control patients. Life-threat
ening complications occurred in the care of three experimental patient
s-and one control patient, while other serious complications occurred
in the care of 16 experimental patients and 17 control patients. Concl
usions: Recommendations based on nonlinear optimization prompted clini
cians to schedule less frequent follow-up for patients taking warfarin
, with no deterioration in anticoagulation control. This approach to s
cheduling can potentially reduce utilization while maintaining quality
of care for patients who require long-term monitoring.